Medline Inc. - Class A common stock (MDLN) Covered Calls
Medline Inc. is the largest manufacturer and distributor of medical-surgical products and supply chain solutions in the United States. Following its 2025 IPO, the company serves the entire continuum of care, including hospitals, surgery centers, and physician offices. Its vertically integrated model encompasses over 300,000 products, ranging from surgical kits and gloves to diagnostic consumables, supported by an expansive global logistics and manufacturing infrastructure.
You can sell covered calls on Medline Inc. - Class A common stock to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for MDLN (prices last updated Fri 4:16 PM ET):
| Medline Inc. - Class A common stock (MDLN) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 43.83 | -0.22 | 43.40 | 44.24 | 14.3M | - | 36 |
| Covered Calls For Medline Inc. - Class A common stock (MDLN) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Mar 20 | 45 | 1.20 | 43.04 | 2.8% | 68.1% | |
| Apr 17 | 45 | 2.50 | 41.74 | 6.0% | 50.9% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Medline Inc. (MDLN) is a global leader in medical-surgical ("med-surg") manufacturing and distribution, offering an end-to-end supply chain solution for healthcare providers. The company operates through two primary segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment manufactures and procures a proprietary portfolio of nearly 200,000 products, including advanced wound care, protective apparel, and anesthesia supplies. The Supply Chain Solutions segment acts as a consolidated logistics partner, distributing hundreds of thousands of third-party products to more than 20,000 delivery points daily.
As of 2026, Medline has successfully transitioned into the public markets following its late 2025 IPO. The company’s business model is characterized by high recurring revenue driven by its "Prime Vendor" relationships, which account for the majority of its sales. These long-term contracts allow Medline to act as the primary supplier for large health systems, providing cost savings through scale while ensuring a high retention rate. To support this volume, the company maintains a massive warehouse footprint and operates its own dedicated truck fleet, MedTrans, ensuring reliable next-day delivery to nearly all U.S. healthcare providers.
Competitive Landscape
Medline operates in a highly consolidated market for medical distribution and services. Its primary competitors include the major national distributors: Cardinal Health, McKesson Corporation, and Cencora. While these rivals have historically dominated the acute care and pharmaceutical distribution space, Medline’s vertical integration—manufacturing a large portion of the products it sells—gives it a distinct advantage in margin control and supply chain resilience.
In the home-based care and surgical supply markets, the company tracks against newly rebranded firms such as Accendra Health (formerly Owens & Minor) and Becton, Dickinson and Company. It also competes with specialized medical suppliers like Baxter International and 3M in categories such as wound care and infection prevention. Despite intense competition from legacy distributors and niche manufacturers, Medline’s "one-stop-shop" value proposition makes it a critical infrastructure partner for modern healthcare systems.
Strategic Outlook and Innovation
The company’s 2026 strategic roadmap focuses on "Digital-First Distribution" and the integration of AI-driven demand forecasting. Following its IPO, Medline has prioritized improving its financial flexibility while continuing to invest in its "Healthcare Run Better" initiative. This includes the expansion of its domestic manufacturing capacity to mitigate the impact of global trade volatility. A major operational milestone is the full deployment of robotics and automated picking systems across its distribution network, aimed at further increasing order accuracy and throughput.
Innovation at Medline is increasingly focused on the transition to "Value-Based Supply Chain" models, where data analytics are used to help health systems reduce waste and standardize product usage. In early 2026, the company introduced its latest generation of environmentally sustainable surgical textiles and products, responding to the growing demand for "green" medical supplies. By leveraging its deep clinical expertise and its significant role in the healthcare ecosystem, Medline intends to remain a resilient leader in the evolving U.S. and international medical supply markets.
| Top 10 Open Interest For Mar 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | QQQ covered calls | 1. | CTMX covered calls | |
| 2. | SLV covered calls | 7. | EWZ covered calls | 2. | MRVL covered calls | |
| 3. | EEM covered calls | 8. | GLD covered calls | 3. | REPL covered calls | |
| 4. | SPY covered calls | 9. | FXI covered calls | 4. | QURE covered calls | |
| 5. | IBIT covered calls | 10. | SOFI covered calls | 5. | PATH covered calls | |
Want more examples? MDIV Covered Calls | MDLZ Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
